Concise review of atrial fibrillation: treatment update considerations in light of AFFIRM and RACE.
作者信息
Bloom Heather L
机构信息
University of California Davis Medical Center, Sacramento, California 95817, USA.
出版信息
Clin Cardiol. 2004 Sep;27(9):495-500. doi: 10.1002/clc.4960270904.
Abstract
Atrial fibrillation (AF) is the most common clinically significant arrhythmia seen by clinicians. Prevalence is as high as 9.0% in patients aged > or = 80 years, and incidence is projected to be more than 5.6 million patients in the U.S. by 2050. Recently, new trials have challenged the traditional belief that rhythm control is inherently superior to rate control in these patients. This article reviews the basic tenets of treatment for AF and discusses how new trial data integrate into these protocols. A concise treatment algorithm is provided and new and upcoming more aggressive interventional treatment options are discussed. This review is designed to help the general practitioner decide how to treat patients in the outpatient setting, evaluate which patients should be hospitalized for management, and which patients should be referred to a cardiologist.
摘要
相似文献
1
Concise review of atrial fibrillation: treatment update considerations in light of AFFIRM and RACE.
Clin Cardiol. 2004 Sep;27(9):495-500. doi: 10.1002/clc.4960270904.
2
Cardiovascular Disease Update: Atrial Fibrillation.
FP Essent. 2017 Mar;454:11-17.
3
[Atrial fibrillation: rhythm control versus rate control? (New evidences from clinical trials)].
Medicina (Kaunas). 2004;40(6):598-603.
4
Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation.
Circulation. 2016 Jul 26;134(4):339-52. doi: 10.1161/CIRCULATIONAHA.116.021727.
5
Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
Am Heart J. 2005 Apr;149(4):650-6. doi: 10.1016/j.ahj.2004.11.015.
6
Management of atrial fibrillation.
Med Clin North Am. 2015 Jul;99(4):781-94. doi: 10.1016/j.mcna.2015.02.007. Epub 2015 Apr 11.
7
Rate versus rhythm control in patients with atrial fibrillation: what the trials really say.
Drugs. 2005;65(12):1651-67. doi: 10.2165/00003495-200565120-00004.
8
A perspective on antiarrhythmic drug therapy to treat atrial fibrillation: there remains an unmet need.
Am Heart J. 2006 Apr;151(4):771-8. doi: 10.1016/j.ahj.2005.06.014.
9
Treatment of atrial fibrillation.
Treat Guidel Med Lett. 2010 Sep;8(97):65-70; quiz 1p preceding 70.
10
Pharmacological cardioversion of atrial fibrillation: current management and treatment options.
Drugs. 2004;64(24):2741-62. doi: 10.2165/00003495-200464240-00003.
引用本文的文献
1
Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.
Eur J Clin Pharmacol. 2006 Aug;62(8):613-9. doi: 10.1007/s00228-006-0154-7. Epub 2006 Jul 4.
2
Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat.
Br J Clin Pharmacol. 2005 Oct;60(4):347-54. doi: 10.1111/j.1365-2125.2005.02449.x.
本文引用的文献
1
Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge.
Am Heart J. 1959 Jul;58(1):59-70. doi: 10.1016/0002-8703(59)90274-1.
2
A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.
N Engl J Med. 2002 Dec 5;347(23):1834-40. doi: 10.1056/NEJMoa021375.
3
A comparison of rate control and rhythm control in patients with atrial fibrillation.
N Engl J Med. 2002 Dec 5;347(23):1825-33. doi: 10.1056/NEJMoa021328.
4
Ablation of atrial fibrillation: a procedure come of age?
Curr Control Trials Cardiovasc Med. 2001;2(2):67-70. doi: 10.1186/cvm-2-2-067.
5
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.
J Am Coll Cardiol. 2001 Oct;38(4):1231-66. doi: 10.1016/s0735-1097(01)01587-x.
6
Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
N Engl J Med. 2001 May 10;344(19):1411-20. doi: 10.1056/NEJM200105103441901.
7
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
JAMA. 2001 May 9;285(18):2370-5. doi: 10.1001/jama.285.18.2370.
8
Radiofrequency catheter ablation of atrial fibrillation initiated by spontaneous ectopic beats.
Curr Cardiol Rep. 2000 Jul;2(4):322-8. doi: 10.1007/s11886-000-0088-0.
9
Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists.
Circulation. 1999 Jun 15;99(23):3028-35. doi: 10.1161/01.cir.99.23.3028.
10
Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group.
Am Heart J. 1999 Jun;137(6):1062-9. doi: 10.1016/s0002-8703(99)70363-7.
Zotero 插件